{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:27:29Z","timestamp":1784312849191,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["S P50 CA 261608"],"award-info":[{"award-number":["S P50 CA 261608"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jaad.2022.11.033","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:43:44Z","timestamp":1669355024000},"page":"802-807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB\/C melanoma: A population-based analysis"],"prefix":"10.1016","volume":"88","author":[{"given":"Cimarron E.","family":"Sharon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Richard J.","family":"Straker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis A.","family":"Gimotty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Y.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara C.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund K.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgos C.","family":"Karakousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10336","key":"10.1016\/j.jaad.2022.11.033_bib1","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/S0140-6736(22)00562-1","article-title":"Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial","volume":"399","author":"Luke","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2022.11.033_bib2","author":"Goodman"},{"issue":"4","key":"10.1016\/j.jaad.2022.11.033_bib4","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jaad.2022.04.025","article-title":"Sentinel lymph node biopsy in patients with clinical stage IIB\/C cutaneous melanoma: a national cohort study","volume":"87","author":"Straker","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2022.11.033_bib7","doi-asserted-by":"crossref","first-page":"i6","DOI":"10.1136\/bmj.i6","article-title":"Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests","volume":"352","author":"Vickers","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2022.11.033_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn Progn Res"},{"key":"10.1016\/j.jaad.2022.11.033_bib9","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"issue":"6","key":"10.1016\/j.jaad.2022.11.033_bib10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1001\/jamadermatol.2022.0976","article-title":"Decision curve analysis and the net benefit of novel tests","volume":"158","author":"Adamson","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2022.11.033_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001491","article-title":"Evaluation of prediction models for decision-making: beyond calibration and discrimination","volume":"10","author":"Holmberg","year":"2013","journal-title":"PLoS Med"},{"issue":"22","key":"10.1016\/j.jaad.2022.11.033_bib12","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1200\/JCO.2011.36.1329","article-title":"Prediction models: revolutionary in principle, but do they do more good than harm?","volume":"29","author":"Vickers","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jaad.2022.11.033_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"issue":"20","key":"10.1016\/j.jaad.2022.11.033_bib14","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJM198005153022003","article-title":"The threshold approach to clinical decision making","volume":"302","author":"Pauker","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2022.11.033_bib15","article-title":"International center-level variation in utilization of completion lymph node dissection and adjuvant systemic therapy for sentinel lymph node positive melanoma at major referral centers","author":"Broman","year":"2022","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.jaad.2022.11.033_bib16","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.jaad.2022.11.033_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.annonc.2020.11.015","article-title":"Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor","volume":"32","author":"El Sharouni","year":"2021","journal-title":"Ann Oncol"},{"issue":"36","key":"10.1016\/j.jaad.2022.11.033_bib18","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jaad.2022.11.033_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jaad.2018.08.022","article-title":"Relationship between age and likelihood of lymph node metastases in patients with intermediate thickness melanoma (1.01-4.00 mm): a National Cancer Database study","volume":"80","author":"Hanna","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2022.11.033_bib20","first-page":"835","article-title":"Therapeutic value of sentinel lymph node biopsy in patients with melanoma: a randomized clinical trial","volume":"157","author":"Crystal","year":"2022","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.jaad.2022.11.033_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archsurg.140.1.85","article-title":"Identifying risk factors for complications following sentinel lymph node biopsy for melanoma","volume":"140","author":"Roaten","year":"2005","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.jaad.2022.11.033_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.2017.75.7724","article-title":"Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology clinical practice guideline update","volume":"36","author":"Wong","year":"2018","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jaad.2022.11.033_bib23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jamasurg.2022.2054","article-title":"Prognostic or therapeutic-the role of sentinel lymph node biopsy in contemporary practice","volume":"157","author":"Rhodin","year":"2022","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.jaad.2022.11.033_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00008390-199810000-00004","article-title":"Nodular histogenetic type -- the most significant factor for thick melanoma: implications for prevention","volume":"8","author":"Bergenmar","year":"1998","journal-title":"Melanoma Res"},{"issue":"12","key":"10.1016\/j.jaad.2022.11.033_bib25","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/jnci\/djz034","article-title":"Distinct clinicopathological and prognostic features of thin nodular primary melanomas: an International study from 17 centers","volume":"111","author":"Dessinioti","year":"2019","journal-title":"J Natl Cancer Inst"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222031334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222031334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:37:01Z","timestamp":1778675821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962222031334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0190962222031334"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2022.11.033","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB\/C melanoma: A population-based analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2022.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}